+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Stem Cells Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027

  • PDF Icon

    Report

  • October 2020
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5327890
Stem cells are divided into two major classes; pluripotent and multipotent. Pluripotent stem cells are replicating cells, which are derived from the embryo or fetal tissues. The pluripotent stem cells facilitate the development of cells and tissues in three primary germ layers such as mesoderm, ectoderm, and endoderm.

Restraints of the Global Stem Cells Market

Major factors hampering the growth of the stem cells market during the forecast period constitutes of high costs, and lack of skilled professionals.

Key features of the study:
  • This report provides in-depth analysis of the global stem cells market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2020–2027), considering 2019, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global stem cells market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Advanced Cell Technology, Inc., Angel Biotechnology Holdings PLC, Bioheart Inc., Lineage Cell Therapeutics., BrainStorm Cell Therapeutics, Inc., California Stem Cell Inc., Celgene Corporation, Takara Bio Europe AB, Cellular Engineering Technologies, Cytori Therapeutics Inc., Osiris Therapeutics, and STEMCELL Technologies Inc
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global stem cells market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

Global Stem Cells Market, By Type:
  • Adult Stem Cells
  • Human Embryonic Stem Cells
  • Induced Pluripotent Stem Cells
  • Natural Rosette Cells
  • Very Small Embryonic Like Stem Cells

Global Stem Cells Market, By Application:
  • Regenerative Medicine
  • Drug Discovery and Development

Global Stem Cells Market, By Technology:
  • Cell Acquisition
  • Cell Production
  • Cryopreservation
  • Expansion and Sub-Culture

Global Stem Cells Market, By Geography:
  • North America

By Country:
  • U.S.
  • Canada
  • Europe

By Country:
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific

By Country:
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America

By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

o Middle East:

By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • Africa

By Country/Region:
  • Central Africa
  • South Africa
  • North Africa
  • Company Profiles
  • Advanced Cell Technology, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Key Strategies
  • Recent Developments
  • Angel Biotechnology Holdings PLC
  • Bioheart Inc.
  • Lineage Cell Therapeutics
  • BrainStorm Cell Therapeutics, Inc.
  • California Stem Cell Inc.
  • Celgene Corporation
  • Takara Bio Europe AB
  • Cellular Engineering Technologies
  • Cytori Therapeutics Inc.
  • Osiris Therapeutics
  • STEMCELL Technologies Inc

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By Application
  • Market Snippet, By Technology
  • Opportunity Map

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • PEST Analysis
  • COVID-19 Impact Analysis

4. Global Stem Cells Market, By Type, 2016 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Adult Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Human Embryonic Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Induced Pluripotent Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Natural Rosette Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends
  • Very Small Embryonic Like Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Segment Trends

5. Global Stem Cells Market, By Application, 2016 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Regenerative Medicine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Drug Discovery and Development
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

6. Global Stem Cells Market, By Technology, 2016 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • Cell Acquisition
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Cell Production
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Cryopreservation
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Expansion and Sub-Culture
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)

7. Global Stem Cells Market, By Regions, 2016 - 2027 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2019 and 2027 (%)
  • Y-o-Y Growth Analysis, 2017-2027
  • Segment Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • U.S.
  • Canada
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2016 - 2027, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape
  • Company Profiles
  • Advanced Cell Technology, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Angel Biotechnology Holdings PLC
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Bioheart Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Lineage Cell Therapeutics
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • BrainStorm Cell Therapeutics, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • California Stem Cell Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Celgene Corporation
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Takara Bio Europe AB
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Cellular Engineering Technologies
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Cytori Therapeutics Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Osiris Therapeutics
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • STEMCELL Technologies Inc
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Section
  • References
  • Research Methodology
  • About us and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Advanced Cell Technology, Inc.
  • Angel Biotechnology Holdings PLC
  • Bioheart Inc.
  • Lineage Cell Therapeutics
  • BrainStorm Cell Therapeutics, Inc.
  • California Stem Cell Inc.
  • Celgene Corporation
  • Takara Bio Europe AB
  • Cellular Engineering Technologies
  • Cytori Therapeutics Inc.
  • Osiris Therapeutics
  • STEMCELL Technologies Inc